Horizon Pharma (HZNP) Tops Q2 EPS by 12c

August 8, 2016 7:02 AM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Horizon Pharma (NASDAQ: HZNP) reported Q2 EPS of $0.62, $0.12 better than the analyst estimate of $0.50. Revenue for the quarter came in at $257.4 million versus the consensus estimate of $234.88 million.

For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment